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Results
Drug omissions discovered by therapeutic reconciliation were reintegrated into the DHU prescription, after medication review. Patient’s
safety was the main focus of the pharmaceutical intervention, though which all medications omissions and incorrect dose detected were
corrected. Pharmaceutical interventions also emphasized storage of medication, identification and collection of expired drugs, and
further enhanced adherence to prescribed treatment. This poster presents first results of an ongoing project.
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Methods
Study design
Sample - The data here presented are from patients hospitalized
between August and September of 2016.
Data sources and Pharmacist Intervention
Objectives
Background
In November 2015 a new model of hospitalization has been
created in Portugal, domiciliary hospitalization unit (DHU). DHU is
an alternative to the conventional hospitalization which provides
hospital care to the acute patient, already existing in some other
countries.1 Care is provided at the patient's own home by a
multidisciplinary team of physicians, nurses and pharmacists.
This model emerges as a possible solution to the A&E excessive
resource witch there is in Portugal.
• To evaluate the existence of pharmacotherapeutic errors
during patient transition across the health care system;
• To integrate a pharmacist into this multidisciplinary team to
detect and solve those errors can through medication
reconciliation;
33 patients 28 patients
20 patients 
included
Patients without outpatient medication
Patients who received the pharmaceutical visit 
during the first day of DHU hospitalization
5 Excluded
8 Excluded
Explore medication 
discrepancies prior to DHU 
Observational 
retrospective design 
To readily act upon 
discrepancies found during DHU
Intervention
prospective design 
Statistical analysis - Statistical Package for the Social Sciences
(SPSS) v.24,0. Descriptive and bivariate analysis have been used
(Spearman correlation coefficient to explore associations
between days of hospitalization and number of medication
discrepancies). The confidence level was set at 5%.
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(SD=6,56)
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The number of omissions was unrelated with the days of
hospitalization (Spearman’s r = -0,134; p = 0,572) 
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The main reasons for hospitalization in DHU were urinary tract
infections (44%), respiratory diseases (20%), acute kidney injury
(12%) and cerebrovascular diseases (12%).
Therapeutic reconciliation was
performed between the
outpatient medications and the
previous services, which were:
A&E (50%), conventional
hospitalization(45%) and DHU
(16%).
Figure 2: Medication prescribed during hospitalization in DHU in addition to outpatient medication. 
Figure 1: Comparasion between outpatient drugs and drug omissions (between outpatient medication 
and the hospital prescription in the mentioned above services).
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